PatientsVille.com Logo

Magnevist Side Effects

PatientsVille

Common Magnevist Side Effects


The most commonly reported Magnevist side effects (click to view or check a box to report):

Nephrogenic Systemic Fibrosis (920)
Urticaria (813)
Nausea (573)
Pruritus (551)
Dyspnoea (517)
Vomiting (511)
Erythema (507)
Anxiety (443)
Joint Range Of Motion Decreased (438)
Pain (425)
Oedema Peripheral (387)
Mobility Decreased (370)
Emotional Distress (361)
Fibrosis (341)
Arthralgia (330)
Deformity (265)
Joint Stiffness (253)
Injury (243)
Joint Contracture (240)
Sneezing (232)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Magnevist Side Effects Reported to FDA



Magnevist Side Effect Report#9992501
Hypoaesthesia, Erythema, Oedema Mouth, Swelling Face
This is a report of a 36-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: nuclear magnetic resonance imaging,haemangioma, who was treated with Magnevist (dosage: Unk Unk, Once, start time:
Feb 24, 2014), combined with: NA. and developed a serious reaction and side effect(s): Hypoaesthesia, Erythema, Oedema Mouth, Swelling Face after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnevist treatment in female patients, resulting in Hypoaesthesia side effect.
Magnevist Side Effect Report#9992496
Throat Irritation, Paraesthesia Mucosal
This report suggests a potential Magnevist Throat Irritation side effect(s) that can have serious consequences. A 37-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging and used Magnevist (dosage: Unk Unk, Once) starting
Mar 05, 2012. After starting Magnevist the patient began experiencing various side effects, including: Throat Irritation, Paraesthesia MucosalAdditional drugs used concurrently: NA. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Throat Irritation, may still occur.
Magnevist Side Effect Report#9972248
Nausea
This Nausea problem was reported by a health professional from US. A 56-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging. On
Feb 28, 2014 this consumer started treatment with Magnevist (dosage: Unk). The following drugs were being taken at the same time: NA. When using Magnevist, the patient experienced the following unwanted symptoms/side effects: NauseaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Nausea, may become evident only after a product is in use by the general population.
Magnevist Side Effect Report#9972243
Vomiting, Sneezing
This Vomiting side effect was reported by a health professional from US. A 38-year-old female patient (weight:NA) experienced the following symptoms/conditions: nuclear magnetic resonance imaging.The patient was prescribed Magnevist (drug dosage: Unk Unk, Once), which was initiated on
Feb 24, 2014. Concurrently used drugs: NA..After starting to take Magnevist the consumer reported adverse symptoms, such as: Vomiting, SneezingThese side effects may potentially be related to Magnevist.
Magnevist Side Effect Report#9961226
Rash, Vomiting, Nausea
This is a report of a 31-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: nuclear magnetic resonance imaging, who was treated with Magnevist (dosage: Unk Unk, Once, start time:
Feb 25, 2014), combined with: NA. and developed a serious reaction and side effect(s): Rash, Vomiting, Nausea after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnevist treatment in female patients, resulting in Rash side effect.
Magnevist Side Effect Report#9919945
Paraesthesia, Unresponsive To Stimuli
This report suggests a potential Magnevist Paraesthesia side effect(s) that can have serious consequences. A 62-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: scan brain,convulsion and used Magnevist (dosage: 20 Ml, Once) starting
Feb 17, 2014. After starting Magnevist the patient began experiencing various side effects, including: Paraesthesia, Unresponsive To StimuliAdditional drugs used concurrently: NA. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Paraesthesia, may still occur.
Magnevist Side Effect Report#9880905
Blood Pressure Systolic Increased, Respiratory Rate Increased, Dyspnoea, Wheezing, Eye Pruritus, Pruritus, Cough, Pain
This Blood Pressure Systolic Increased problem was reported by a consumer or non-health professional from US. A 23-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: scan with contrast. On
Dec 04, 2013 this consumer started treatment with Magnevist (gadopentetate Dimelumine) (dosage: 19 Ml One Time Dose, Iv Via Power Inection). The following drugs were being taken at the same time: NA. When using Magnevist (gadopentetate Dimelumine), the patient experienced the following unwanted symptoms/side effects: Blood Pressure Systolic Increased, Respiratory Rate Increased, Dyspnoea, Wheezing, Eye Pruritus, Pruritus, Cough, PainThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Blood Pressure Systolic Increased, may become evident only after a product is in use by the general population.
Magnevist Side Effect Report#9877877
Stevens-johnson Syndrome, Oral Mucosa Erosion, Abnormal Sensation In Eye, Erythema, Skin Erosion, Epidermal Necrosis
This Stevens-johnson Syndrome side effect was reported by a physician from JP. A 38-year-old female patient (weight:NA) experienced the following symptoms/conditions: nuclear magnetic resonance imaging abdominal,ovarian cancer,antipyresis.The patient was prescribed Magnevist (drug dosage: 10 Ml (1ml/s For About 10 Seconds), Once), which was initiated on
Jan 15, 2014. Concurrently used drugs: NA..After starting to take Magnevist the consumer reported adverse symptoms, such as: Stevens-johnson Syndrome, Oral Mucosa Erosion, Abnormal Sensation In Eye, Erythema, Skin Erosion, Epidermal NecrosisThese side effects may potentially be related to Magnevist.
Magnevist Side Effect Report#9859039
Respiratory Distress, Dizziness, Headache, Urticaria
This is a report of a 59-year-old female patient (weight: NA) from VI, suffering from the following health symptoms/conditions: nuclear magnetic resonance imaging abdominal, who was treated with Magnevist (dosage: 17 Ml, Once, start time:
Jan 23, 2014), combined with: NA. and developed a serious reaction and side effect(s): Respiratory Distress, Dizziness, Headache, Urticaria after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnevist treatment in female patients, resulting in Respiratory Distress side effect.
Magnevist Side Effect Report#9852564
Erythema, Anaphylactic Reaction, Distributive Shock, Slow Response To Stimuli
This report suggests a potential Magnevist Erythema side effect(s) that can have serious consequences. A 40-year-old female patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging abdominal,ovarian cancer,anaemia and used Magnevist (dosage: 14 Ml, Once) starting
Oct 29, 2013. After starting Magnevist the patient began experiencing various side effects, including: Erythema, Anaphylactic Reaction, Distributive Shock, Slow Response To StimuliAdditional drugs used concurrently: NA.The patient was hospitalized. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Erythema, may still occur.
Magnevist Side Effect Report#9842736
Paraesthesia Mucosal, Paraesthesia
This Paraesthesia Mucosal problem was reported by a health professional from US. A 58-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging. On
Jan 20, 2014 this consumer started treatment with Magnevist (dosage: 15 Ml, Once). The following drugs were being taken at the same time: NA. When using Magnevist, the patient experienced the following unwanted symptoms/side effects: Paraesthesia Mucosal, ParaesthesiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Paraesthesia Mucosal, may become evident only after a product is in use by the general population.
Magnevist Side Effect Report#9825992
Urticaria, Pruritus, Contrast Media Reaction
This Urticaria side effect was reported by a consumer or non-health professional from US. A 31-year-old female patient (weight:NA) experienced the following symptoms/conditions: nuclear magnetic resonance imaging brain.The patient was prescribed Magnevist (drug dosage: 14 Ml, Once), which was initiated on
Jan 14, 2014. Concurrently used drugs: NA..After starting to take Magnevist the consumer reported adverse symptoms, such as: Urticaria, Pruritus, Contrast Media ReactionThese side effects may potentially be related to Magnevist.
Magnevist Side Effect Report#9825981
Tension Headache, Headache, Sensation Of Pressure, Anxiety
This is a report of a 71-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: nuclear magnetic resonance imaging brain,hypoaesthesia, who was treated with Magnevist (dosage: 15 Ml, Unk, start time:
Jan 13, 2014), combined with: NA. and developed a serious reaction and side effect(s): Tension Headache, Headache, Sensation Of Pressure, Anxiety after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnevist treatment in female patients, resulting in Tension Headache side effect.
Magnevist Side Effect Report#9821919
Tension Headache, Headache, Intracranial Pressure Increased
This report suggests a potential Magnevist Tension Headache side effect(s) that can have serious consequences. A 51-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging,headache and used Magnevist (dosage: 18 Ml, Once) starting
Jan 13, 2014. After starting Magnevist the patient began experiencing various side effects, including: Tension Headache, Headache, Intracranial Pressure IncreasedAdditional drugs used concurrently: NA. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Tension Headache, may still occur.
Magnevist Side Effect Report#9818618
Pruritus
This Pruritus problem was reported by a health professional from US. A 52-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging. On NS this consumer started treatment with Magnevist (dosage: Unk Unk, Once). The following drugs were being taken at the same time: NA. When using Magnevist, the patient experienced the following unwanted symptoms/side effects: PruritusAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pruritus, may become evident only after a product is in use by the general population.
Magnevist Side Effect Report#9813881
Pruritus, Flushing
This Pruritus side effect was reported by a health professional from US. A 61-year-old female patient (weight:NA) experienced the following symptoms/conditions: nuclear magnetic resonance imaging brain.The patient was prescribed Magnevist (drug dosage: Unk Unk, Once), which was initiated on
Dec 09, 2013. Concurrently used drugs: NA..After starting to take Magnevist the consumer reported adverse symptoms, such as: Pruritus, FlushingThese side effects may potentially be related to Magnevist.
Magnevist Side Effect Report#9795384
Urticaria
This is a report of a 47-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: nuclear magnetic resonance imaging breast, who was treated with Magnevist (dosage: 20 Ml, Once, start time:
Dec 31, 2013), combined with: NA. and developed a serious reaction and side effect(s): Urticaria after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnevist treatment in female patients, resulting in Urticaria side effect.
Magnevist Side Effect Report#9794179
Urticaria
This report suggests a potential Magnevist Urticaria side effect(s) that can have serious consequences. A 57-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging,breast disorder and used Magnevist (dosage: 20 Ml, Once) starting
Dec 30, 2013. After starting Magnevist the patient began experiencing various side effects, including: UrticariaAdditional drugs used concurrently: NA. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Urticaria, may still occur.
Magnevist Side Effect Report#9785442
Nephrogenic Systemic Fibrosis
This Nephrogenic Systemic Fibrosis problem was reported by a health professional from DK. A 59-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Jun 26, 2006 this consumer started treatment with Magnevist (dosage: NA). The following drugs were being taken at the same time:
  • Omniscan
  • Prednisolone
When using Magnevist, the patient experienced the following unwanted symptoms/side effects: Nephrogenic Systemic FibrosisAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Nephrogenic Systemic Fibrosis, may become evident only after a product is in use by the general population.
Magnevist Side Effect Report#9778377
Phlebitis, Pain, Thrombosis
This Phlebitis side effect was reported by a health professional from BR. A 29-year-old male patient (weight:NA) experienced the following symptoms/conditions: nuclear magnetic resonance imaging brain.The patient was prescribed Magnevistan (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Magnevistan the consumer reported adverse symptoms, such as: Phlebitis, Pain, ThrombosisThese side effects may potentially be related to Magnevistan.
Magnevist Side Effect Report#9772424
Urticaria
This is a report of a 49-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: arteriogram, who was treated with Magnevist (dosage: 35 Ml, Once, start time:
Dec 17, 2013), combined with: NA. and developed a serious reaction and side effect(s): Urticaria after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnevist treatment in male patients, resulting in Urticaria side effect.
Magnevist Side Effect Report#9770544
Nephrogenic Systemic Fibrosis, Arthralgia, Musculoskeletal Stiffness, Joint Contracture, Mobility Decreased, Gait Disturbance, Abasia, Skin Discolouration, Joint Stiffness
This report suggests a potential Magnevist Nephrogenic Systemic Fibrosis side effect(s) that can have serious consequences. A 43-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging abdominal,complications of transplanted kidney,abdominal pain,angiogram,intestinal ischaemia,nuclear magnetic resonance imaging brain,blood prolactin increased and used Magnevist (dosage: 20 Ml, Once) starting
Oct 05, 2005. After starting Magnevist the patient began experiencing various side effects, including: Nephrogenic Systemic Fibrosis, Arthralgia, Musculoskeletal Stiffness, Joint Contracture, Mobility Decreased, Gait Disturbance, Abasia, Skin Discolouration, Joint StiffnessAdditional drugs used concurrently: NA. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Nephrogenic Systemic Fibrosis, may still occur.
Magnevist Side Effect Report#9767806
Anaphylactic Shock, Laryngeal Oedema, Dyspnoea, Cyanosis, Cardio-respiratory Arrest
This Anaphylactic Shock problem was reported by a consumer or non-health professional from BR. A 58-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: nuclear magnetic resonance imaging abdominal. On
Dec 10, 2013 this consumer started treatment with Magnevistan (dosage: 15 Ml, Once). The following drugs were being taken at the same time: NA. When using Magnevistan, the patient experienced the following unwanted symptoms/side effects: Anaphylactic Shock, Laryngeal Oedema, Dyspnoea, Cyanosis, Cardio-respiratory ArrestThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Anaphylactic Shock, may become evident only after a product is in use by the general population.
Magnevist Side Effect Report#9767651
Hyperhidrosis, Tremor, Oropharyngeal Discomfort, Nausea
This Hyperhidrosis side effect was reported by a consumer or non-health professional from US. A 49-year-old male patient (weight:NA) experienced the following symptoms/conditions: nuclear magnetic resonance imaging,pain,dermatitis allergic.The patient was prescribed Magnevist (drug dosage: 14 Ml, Once), which was initiated on
Dec 16, 2013. Concurrently used drugs: NA..After starting to take Magnevist the consumer reported adverse symptoms, such as: Hyperhidrosis, Tremor, Oropharyngeal Discomfort, NauseaThese side effects may potentially be related to Magnevist.
Magnevist Side Effect Report#9760223
Urticaria, Dyspnoea
This is a report of a 46-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: nuclear magnetic resonance imaging brain,cerebrovascular accident, who was treated with Magnevist (dosage: 18 Ml, Once, start time:
Dec 06, 2013), combined with: NA. and developed a serious reaction and side effect(s): Urticaria, Dyspnoea after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnevist treatment in male patients, resulting in Urticaria side effect.


1 of 199 


The appearance of Magnevist on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Magnevist Side Effects for Women?

Women Side EffectsReports
Urticaria 578
Nephrogenic Systemic Fibrosis 436
Pruritus 386
Nausea 341
Erythema 313
Dyspnoea 308
Vomiting 289
Pain 237
Joint Range Of Motion Decreased 223
Oedema Peripheral 213

What are common Magnevist Side Effects for Men?

Men Side EffectsReports
Nephrogenic Systemic Fibrosis 484
Anxiety 236
Nausea 227
Urticaria 218
Vomiting 218
Joint Range Of Motion Decreased 215
Dyspnoea 203
Erythema 192
Pain 188
Emotional Distress 187

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Magnevist reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Magnevist Side Effects

    Did You Have a Magnevist Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Magnevist for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Magnevist Safety Alerts, Active Ingredients, Usage Information

    NDC50419-188
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameMagnevist
    Namegadopentetate dimeglumine
    Dosage FormINJECTION
    RouteINTRAVENOUS
    On market since20101214
    LabelerBayer HealthCare Pharmaceuticals Inc.
    Active Ingredient(s)GADOPENTETATE DIMEGLUMINE
    Strength(s)469.01
    Unit(s)mg/mL
    Pharma Class

    Magnevist Dosage, Warnings, Usage.

    Side Effects reported to FDA: 4951

    Magnevist safety alerts: 2007 2006

    Reported deaths: 474

    Reported hospitalizations: 648

    Gadolinium-containing Contrast Agents for Magnetic Resonance Imaging (MRI): Magnevist, MultiHance, Omniscan, OptiMARK, ProHance

    Audience: Radiologists, Nephrologists, Dermatologists, other healthcare professionals

    [UPDATED 09/28/2007] Manufacturers of Gadolinium-based contrast agents issued a Dear Healthcare Professional letter to inform healthcare professionals of the addition of a BOXED WARNING and revisions to the WARNING section of the prescribing information for Gadolinium-based contrast agents as listed above used in Magnetic Resonance Imaging (MRI).

    [Posted 05/23/2007] FDA notified healthcare professionals of the Agency's request for the addition of a boxed warning and new warnings about the risk of nephrogenic systemic fibrosis (NSF) to the full prescribing information for all gadolinium-based contrast agents (GBCAs). The new prescribing information FDA is requesting highlights and describes the risk for NSF following exposure to a GBCA in patients with acute or chronic severe renal insufficiency (glomerular filtration rate <30 mL/min/1.73m2) and patients with acute renal insufficiency of any severity due to the hepato-renal syndrome or in the peri-operative liver transplantation period. Healthcare professionals should avoid the use of a GBCA in these patients unless the diagnostic information is essential and not available with non-contrast enhanced magnetic resonance imaging.

    [September 2007 - Letter - Bayer, GE-Healthcare, BRACCO, and MALLINCKRODT]
    [May 2007 - Magnevist label - Bayer Healthcare Pharmaceuticals]
    [May 2007 - MultiHance label - Bracco Diagnostics Inc.]
    [September 2007 - Omniscan label - GE Healthcare]
    [May 2007 - OptiMARK label - Mallinckrodt Inc.]
    [May 2007 - ProHance label - Bracco Diagnostics, Inc.]

     

    [May 23, 2007 - News Release - FDA]
    [May 23, 2007 - Information for Healthcare Professionals - FDA]
    [May 23, 2007 - Q&A - FDA]

     

    Previous MedWatch Alerts:

    [June 08, 2006]

    Latest Magnevist clinical trials

    Magnevist Reviews

    No reviews, be a first to report a side effect via side effect reporting form